SOURCE: PHT Corporation

PHT Corporation

June 08, 2009 09:00 ET

PHT Corporation Names Diana Pearson Director of Global Partnerships

Global ePRO Market Leader Welcomes Back 30-Year Business and Scientific Professional as It Continues Strong 2009 Growth

BOSTON, MA--(Marketwire - June 8, 2009) - PHT Corporation, the world's leading provider of electronic patient reported outcome (ePRO) solutions used in more than 400 clinical trials, is thrilled to announce that Diana "Dee" Pearson joined the company as Director of Global Partnerships.

Ms. Pearson has more than 30 years' experience in clinical research and biopharmaceutical sales, including 4 years at PHT. During this time she played an instrumental role in commercializing PHT's LogPad ePRO system, establishing compliance, launching the ASP sales model, and forging relationships with key industry members.

PHT Global Director of Sales Nick Randazzo said, "We're very happy to welcome Dee back. Her professionalism, integrity and market knowledge will contribute to PHT's continued market dominance as more biopharmaceutical companies rely on our ePRO solutions to bring drugs and therapies to market economically, safely and quickly."

Ms. Pearson previously held positions at PharmaPros Corporation, Lincoln Technologies (a Phase Forward subsidiary) and Domain Pharma. At Domain, Ms. Pearson earned the top company sales award and was a member of the President's Club. She received her BA in Psychology from the State University of New York and her MA in Experimental Psychology from Kent State University.

About PHT Corporation

PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 400 clinical trials by 100 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePad™ Tablet deliver the voice of the patient, in 85 languages, from homes and sites in 64 countries around the world. By capturing high-quality and time-stamped assessments with minimal respondent burden, trial sponsors are able to run smaller and more conclusive clinical research programs resulting in significant R&D cost savings. Real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry's premier study archive. Patient experiences captured firsthand by PHT's ePRO Product Suite have been used successfully in at least 12 NDA submissions and seven approvals to date. For more information, review interactive product demonstrations at the award-winning www.phtcorp.com.

PHT, LogPad, eSense, StudyWorks, SafetyPRO and SitePad are among the registered trademarks and trademarks of PHT Corporation.

Contact Information